Efficacy of Irinotecan and Capecitabine Versus(vs) Cisplatin and Capecitabine in Patients With Esophago-Gastric Cancer
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine which Arm (capecitabine + irinotecan versus
capecitabine + cisplatin) shows higher response rates in the treatment of advanced
gastric-oesophagal cancer
Furthermore, comparison of progression-free survival, 1-year survival, Quality of Life and
safety